Additionally, hs-cTnI may be better suitable for ruling in MI in patients with known CKD, as patients with CKD stage 3a or higher had elevated hs-cTnT in a non-MI setting more frequently than elevated hs-cTnI. Here, TNNT2 is linked to chronic kidney disease.